tiprankstipranks
Pharvaris N.V. (PHVS)
NASDAQ:PHVS
US Market
Want to see PHVS full AI Analyst Report?

Pharvaris (PHVS) Blogger Opinions & Sentiment

182 Followers

Blogger Sentiment

Bullish: 100.00%
Sector Average
Bullish
PHVS Blogger sentiment is based on 3 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
33% SeekingAlpha
33% Zacks
34% Investing
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Wall Street Analysts Think Pharvaris (PHVS) Could Surge 43.03%: Read This Before Placing a Bet
Zacks
Pharvaris: Biotech With De-Risked Phase 3 Readout Coming, Initiating With A Buy Rating
SeekingAlpha
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of PHVS?
Seeking Alpha’s Willow Tree Research has a Bullish Sentiment.
    What do Motley Fool contributors think of PHVS?
    Currently there's no blogger sentiment for PHVS.
    What Is PHVS’s Blogger Sentiment?
    PHVS’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for PHVS?
      The most recent blogger prediction for PHVS was made by NASDAQ:PHVS, who was Bullish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          TEMTempus AI, Inc. Class A
          DRTSAlpha Tau Medical Ltd
          MLTXMoonLake Immunotherapeutics
          CLVLFClinuvel Pharmaceuticals
          ZVRAZevra Therapeutics